comparemela.com

Latest Breaking News On - Trevi therapeutics - Page 1 : comparemela.com

Frazier Life Sciences Management L P Purchases 500,000 Shares of Trevi Therapeutics, Inc (NASDAQ:TRVI)

Frazier Life Sciences Management L.P. lifted its position in shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) by 7.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,381,090 shares of the company’s stock after purchasing an additional 500,000 shares during […]

Auxilius Revenue Grows 800% in 2023, Raises $10M to Scale Clinical Trial Financial Management Platfo

Rapid growth and strong partnerships with over 50 innovative biopharma companies power Auxilius's momentum ahead of its latest fundraiseNEW YORK, NY / ACCESSWIRE / June 11, 2024 / Auxilius, the first Clinical Trial Financial Management (CTFM) software which enables life science finance, accounting, and clinical oper.

Auxilius Revenue Grows 800% in 2023, Raises $10M to Scale Clinical Trial Financial Management Platform

Auxilius Revenue Grows 800% in 2023, Raises $10M to Scale Clinical Trial Financial Management Platform
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Auxilius Revenue Grows 800% in 2023, Raises $10M to Scale Clinical

Auxilius Revenue Grows 800% in 2023, Raises $10M to Scale Clinical
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Auxilius Revenue Grows 800% in 2023, Raises $10M to Scale Clinical Trial Financial Management Platform

Rapid growth and strong partnerships with over 50 innovative biopharma companies power Auxilius's momentum ahead of its latest fundraiseNEW YORK, NY / ACCESSWIRE / June 11, 2024 / Auxilius, the first Clinical

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.